Pr. Mazal et al., LANGERHANS CELL HISTIOCYTOSIS OF THE HYPOTHALAMUS - DIAGNOSTIC-VALUE OF IMMUNOHISTOCHEMISTRY, Clinical neuropathology, 15(2), 1996, pp. 87-91
The immunophenotype of 6 cases of Langerhans cell histiocytosis (LCH)
of the hypothalamus and 3 cases of cranial bone manifestation of LCH w
as investigated by means of immunohistochemistry on paraffin sections.
Antibodies against S 100 protein, lysozyme, CD68 (PG-M1), CD68 (KP1),
HLA-DR, beta(2) microglobulin, placental alkaline phosphatase (FLAP),
the monoclonal antibody MAC 387, and a monoclonal antibody against CD
1a were used, All examined cases showed positive staining of lesional
cells for S 100 protein, HLA-DR, beta(2) microglobulin, macrophage ass
ociated markers and CD1a. According to the ''confidence levels'' of th
e Writing Group of the Histiocyte Society [Chu et al. 1487], a ''defin
ite diagnosis'' of LCH requires the demonstration either of Birbeck gr
anules in lesional cells by electron microscopy, or of CD1a antigenic
determinants on the surface of lesional cells. Since electron microsco
py of these rare CNS lesions is not possible in many cases, we are now
able to give a definite diagnosis of LCH of the hypothalamus by means
of immunohistochemistry for CD1a on routinely fixed and processed tis
sue.